Monitored anesthesia care with remimazolam for gynecological day surgeries: Case reports

Monitored anesthesia care with remimazolam for gynecological day surgeries: Case reports

Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery. Remimazolam is a newly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical case reports 2022-11, Vol.10 (11), p.e6536-n/a
Hauptverfasser: Choi, So Ron, Kim, Tae Hyung, Eom, Deuk Won, Jung, Ji Wook, Park, Sang Yoong
Format: Artikel
Sprache:eng
Schlagworte:
ambulatory surgery
Anesthesia
Biopsy
Blood pressure
Cardiac arrhythmia
Case Report
Case reports
Consciousness
Fainting
Fentanyl
Heart rate
Hypotension
Informed consent
outpatient procedures
Oxygen saturation
Patient satisfaction
sedation
Surgery
ultra‐short acting benzodiazepine
Vital signs
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery. Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. Considering these advantages, we provided monitored anesthesia care with remimazolam for gynecological day surgery and achieved successful sedation without adverse events.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.6536